182 related articles for article (PubMed ID: 21195973)
1. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates.
Huang WC; Lee CH; Liu JW
J Microbiol Immunol Infect; 2010 Dec; 43(6):470-7. PubMed ID: 21195973
[TBL] [Abstract][Full Text] [Related]
2. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases.
Arda B; Yamazhan T; Sipahi OR; Islekel S; Buke C; Ulusoy S
Int J Antimicrob Agents; 2005 May; 25(5):414-8. PubMed ID: 15848297
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
4. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
[TBL] [Abstract][Full Text] [Related]
6. Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.
Muñoz-Cobo B; Sancho-Tello S; Costa E; Bravo D; Torregrosa I; de Lomas JG; Navarro D
Int J Antimicrob Agents; 2011 Mar; 37(3):278-9. PubMed ID: 21269809
[No Abstract] [Full Text] [Related]
7. Vancomycin minimum inhibitory concentrations (MICs) for meticillin-resistant Staphylococcus aureus (MRSA) in Hong Kong.
Ip M; Chau SS; Lui SL; Leung E; Ling T
Int J Antimicrob Agents; 2010 Oct; 36(4):386-7. PubMed ID: 20702065
[No Abstract] [Full Text] [Related]
8. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J
Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023
[TBL] [Abstract][Full Text] [Related]
10. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
[No Abstract] [Full Text] [Related]
11. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections].
Fedulov D; Mihalache DG
Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725
[No Abstract] [Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
14. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?
Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A
Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589
[No Abstract] [Full Text] [Related]
15. Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus Isolates from 2000 to 2007.
Zheng X; Qi C; Arrieta M; O'Leary A; Wang D; Shulman ST
Pediatr Infect Dis J; 2010 Sep; 29(9):882-4. PubMed ID: 20453708
[TBL] [Abstract][Full Text] [Related]
16. Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus.
Lu CH; Chang WN
Clin Infect Dis; 2000 Sep; 31(3):723-7. PubMed ID: 11017822
[TBL] [Abstract][Full Text] [Related]
17. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Golden M; Shaib W; Havill N
Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
[No Abstract] [Full Text] [Related]
18. Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.
Pedersen M; Benfield TL; Skinhoej P; Jensen AG
BMC Infect Dis; 2006 Mar; 6():49. PubMed ID: 16542437
[TBL] [Abstract][Full Text] [Related]
19. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
[No Abstract] [Full Text] [Related]
20. Susceptibility of Staphylococcus aureus to vancomycin: analysis of minimum inhibitory concentrations in two tertiary care hospitals in eastern South Dakota.
Laible BR; Hellwig TR; Hedge DD
S D Med; 2011 Mar; 64(3):91-5. PubMed ID: 21473519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
